Risk of Malignancy in Resected Cystic Tumors of the Pancreas ≤3 cm in Size: Is it Safe to Observe Asymptomatic Patients? A Multi-institutional Report
Lee C, Scheiman J, Anderson M, Hines O, Reber H, Farrell J, Kochman M, Foley P, Drebin J, Oh Y, Ginsberg G, Ahmad N, Merchant N, Isbell J, Parikh A, Stokes J, Bauer T, Adams R, Simeone D. Risk of Malignancy in Resected Cystic Tumors of the Pancreas ≤3 cm in Size: Is it Safe to Observe Asymptomatic Patients? A Multi-institutional Report. Journal Of Gastrointestinal Surgery 2007, 12: 234-242. PMID: 18040749, DOI: 10.1007/s11605-007-0381-y.Peer-Reviewed Original ResearchConceptsCystic pancreatic tumorsPancreatic resectionFemale patientsCystic neoplasmsRadiographic featuresPancreatic tumorsRecent international consensus guidelinesHigh-volume pancreatic centersPancreatic resection databaseGroup of patientsInternational consensus guidelinesPresence of malignancyPrevalence of malignancyMagnetic resonance imagingAsymptomatic patientsMale patientsPancreatic centersConsensus guidelinesPathological dataMalignant pathologyEndoscopic ultrasoundHigh incidencePatientsMalignancyGreater incidenceEVALUATION OF THE CONSENSUS GUIDELINES FOR THE OPERATIVE MANAGEMENT OF SIDE BRANCH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF PANCREAS
Tang R, Weinberg B, Dawson D, Chaudhari V, Raman S, Reber H, Hines O, Tomlinson J, Farrell J. EVALUATION OF THE CONSENSUS GUIDELINES FOR THE OPERATIVE MANAGEMENT OF SIDE BRANCH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF PANCREAS. Pancreas 2007, 35: 430-431. DOI: 10.1097/01.mpa.0000297797.88293.13.Peer-Reviewed Original Research